IPCA Laboratories Ltd IPCALAB-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 05/23/22 IST
978.05UNCH (UNCH)
52 week range
925.20 - 1,383.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close978.05
  • 52 Week High1,383.10
  • 52 Week High Date09/15/21
  • 52 Week Low925.20
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap3,221.09M
  • Shares Out253.7M
  • 10 Day Average Volume191,952.45
  • Dividend6.00
  • Dividend Yield0.61%
  • Beta-
  • YTD % Change-9.73

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close978.05
  • 52 Week High1,383.10
  • 52 Week High Date09/15/21
  • 52 Week Low925.20
  • 52 Week Low Date02/24/22
  • Market Cap3,221.09M
  • Shares Out253.7M
  • 10 Day Average Volume191,952.45
  • Dividend6.00
  • Dividend Yield0.61%
  • Beta-
  • YTD % Change-9.73

RATIOS/PROFITABILITY

  • EPS (TTM)32.17
  • P/E (TTM)30.40
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/22/2021
  • Div Amount8.00
  • Split Date-
  • Split Factor-

Latest On IPCA Laboratories Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol...
Premchand Godha
Executive Chairman of the Board, Chief Executive Officer, Managing Director
Ajit Jain
Chief Financial Officer, Joint Managing Director, Executive Director
Address
142 AB, Kandivli Industrial Estate
Kandivli (West)
Mumbai
400067
India